Related Experiment Video
Updated: Oct 4, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral
1Laboratory of Pediatric Endocrinology, Department of Pediatrics, Scientific Institute H. S. Raffaele, Italy.
Insights
Highly active antiretroviral therapy (HAART) is linked to decreased bone mineral density (BMD) in children with HIV. This bone loss may be a lifelong risk, potentially worsened by lipodystrophy.
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Bone Metabolism
Background:
- Osteopenia is a concern in children with HIV.
- The impact of highly active antiretroviral therapy (HAART) on bone health in pediatric HIV is not fully understood.
- Understanding the etiology of osteopenia in this population is crucial for long-term management.
Purpose of the Study:
- To evaluate the occurrence of osteopenia in children receiving HAART.
- To define the aetiology of osteopenia in HIV-infected children on HAART.
- To assess the relationship between HAART, lipodystrophy, and bone mineral density (BMD).
Main Methods:
- Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry in 40 vertically HIV-infected children (35 on HAART, 5 untreated).
- Bone turnover markers (PINP, BALP, NTx) were analyzed.
- Results were compared to 314 healthy controls, with adjustments for confounding variables.
Main Results:
- Children on HAART exhibited significantly lower spine and total body BMD compared to both untreated HIV-infected children and healthy controls.
- HAART-treated children with lipodystrophy showed the lowest total body BMD.
- Bone turnover markers (BALP, PINP, NTx) were elevated in HAART-treated children, indicating increased bone remodeling.
Conclusions:
- HAART may represent a novel risk factor for lifelong osteoporosis in children.
- Increased bone turnover contributes to the observed decrease in BMD.
- The severity of osteopenia in children on HAART appears correlated with the presence of lipodystrophy.
Objectives:
To evaluate the occurrence and define the aetiology of osteopenia in children receiving highly active antiretroviral therapy (HAART).
Methods:
Bone mineral density (BMD) of total body and lumbar spine (L2-L4) was assessed by dual-energy X-ray absorptiometry in 40 children vertically infected with HIV: 35 taking HAART and five naive to any antiretroviral treatment (untreated). Six HAART-treated children showed clinical evidence of lipodystrophy. N-terminal propeptide of type-I procollagen (PINP), bone-specific alkaline phosphatase (BALP) and N-terminal telopeptide of type I collagen (NTx) were measured. Results were compared with those obtained in 314 healthy controls. Differences between HIV-positive and healthy children and within the HIV-positive group were assessed by multivariate analyses, controlling for confounding variables (age, sex, weight and height).
Results:
HAART-treated children showed lower spine BMD values than untreated (P = 0.045) and healthy (P = 0.004) children and lower total body BMD values than untreated (P = 0.012) and healthy (P < 0.0001) children. Spine and total body BMD were similar between untreated and healthy children. Total body BMD was lower (P < 0.005) in HAART-treated children with lipodystrophy than in untreated patients, while children on HAART but without lipodystrophy had intermediate values. BALP, PINP and NTx were similar among untreated and healthy children. HAART-treated children had higher BALP levels than healthy (P = 0.0007) and untreated (P = 0.045) children. PINP values showed the same trend as BALP. HAART-treated children had higher NTx urine levels than healthy (P < 0.0001) and untreated (P = 0.041) children.
Conclusions:
HAART seems a new risk factor for life-long osteoporosis in children. An increased rate of bone turnover causes BMD decrease. Severity of osteopenia seems to be related to lipodystrophy.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Retrovirus Life Cycles
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
